Tokyo, Japan

Hideo Iba


 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Kanagawa, JP (2006)
  • Tokyo, JP (2004 - 2020)
  • Chiba, JP (2022)

Company Filing History:


Years Active: 2004-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Hideo Iba in Cancer Treatment

Introduction

Hideo Iba, a renowned inventor based in Tokyo, Japan, has made significant contributions to the field of cancer treatment through his innovative approaches. With a notable portfolio of six patents, Iba’s research focuses on developing novel techniques that aim to combat tumors effectively.

Latest Patents

One of Hideo Iba's most significant recent patents is a technique for treating cancer through the use of structurally-reinforced S-TuD. This patent outlines a composition that includes an miRNA inhibitory complex, which is instrumental in the prevention or treatment of tumors. The composition comprises RNA or its analogs, alongside a method for utilizing this composition to inhibit tumor growth.

Another pivotal patent from Iba is a method for suppressing tumors by inhibiting the miR-200 family. His research demonstrates that tumor growth can be significantly suppressed in vivo by targeting specific miRNA sequences, resulting in a remarkable reduction of tumorigenicity across various subpopulations of tumor cells. This innovative approach offers promising therapeutic potential for existing tumors.

Career Highlights

Throughout his career, Hideo Iba has collaborated with prestigious institutions, enhancing his research capabilities. He is associated with the University of Tokyo, where he has contributed to cutting-edge research in cancer therapeutics. Additionally, Iba has worked with Eisai Company, Limited, a key player in the pharmaceutical industry, where he further honed his skills in biotechnology and drug development.

Collaborations

Iba’s impactful work is often supported by collaborations with esteemed colleagues, including Takeshi Haraguchi and Tohru Arai. Together, they have explored various dimensions of cancer treatment, leveraging their collective expertise to drive innovation in the sector.

Conclusion

Hideo Iba's relentless pursuit of innovative cancer treatment techniques demonstrates his commitment to improving patient outcomes. His patents reflect a significant advancement in therapeutic strategies, paving the way for future discoveries in oncology. With a robust career characterized by meaningful collaborations and groundbreaking patents, Iba continues to inspire the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…